Johnson & Johnson (JNJ) Liabilities and Shareholders Equity (2009 - 2026)

Johnson & Johnson's Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $200.9 billion for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 3.73% year-over-year to $200.9 billion; the TTM figure through Mar 2026 stood at $786.3 billion (up 7.25% YoY), while the FY2025 annual figure was $199.2 billion, up 10.61% from the prior year.
• Liabilities and Shareholders Equity came in at $200.9 billion for Q1 2026 at Johnson & Johnson, up from $199.2 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $200.9 billion in Q1 2026 to a low of $166.1 billion in Q4 2023.
• A 5-year average of $184.1 billion and a median of $181.6 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity decreased 12.25% in 2024 and advanced 12.62% in 2025, its largest moves.
• Johnson & Johnson's Liabilities and Shareholders Equity stood at $175.1 billion in 2022, then decreased by 4.32% to $167.6 billion in 2023, then advanced by 7.49% to $180.1 billion in 2024, then advanced by 10.61% to $199.2 billion in 2025, then rose by 0.85% to $200.9 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $200.9 billion, $199.2 billion, and $192.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison